Efficacy, safety and pharmacokinetic profile of pasteurized intramuscular anti-hepatitis B immunoglobulin for the prophylaxis of hepatitis B virus recurrence after liver transplantation

@article{Filipponi2007EfficacySA,
  title={Efficacy, safety and pharmacokinetic profile of pasteurized intramuscular anti-hepatitis B immunoglobulin for the prophylaxis of hepatitis B virus recurrence after liver transplantation},
  author={F. Filipponi and P. Carrai and P. Simone and A. Franchello and R. Romagnoli and M. Salizzoni},
  journal={Digestive and Liver Disease},
  year={2007},
  volume={39},
  pages={34-34}
}
Background. Combined prophylaxis with hyperimmune human mmunoglobulins (HBIG) and anti-nucleoside analogues has greatly mproved the outcome of liver transplantation (LT) for hepatitis B virus HBV)-related disease. This result is usually achieved by maintaining a stable nti-HBs titre ≥150 U/l indefinitely. However, the optimal way of adminstration and schedule in order to optimize costs and patients’ compliance eeds further investigation. Methods. We assessed the efficacy in preventing HBV… Expand
The prevention of viral recurrence in the long term.
  • A. Marzano
  • Medicine
  • Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
  • 2009
Prophylaxis of hepatitis B virus recurrence after liver transplantation.